Arctiin targets oxidative stress and inflammation, restores Neuregulin-1, and improves neurobehavioral outcomes in neonatal hypoxic-ischemic brain injury

Current Research in Pharmacology and Drug Discovery · Published 2026-01-01 · DOI 10.1016/j.crphar.2026.100253

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.crphar.2026.100253

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Abelacimab: A leap forward in anticoagulation with FXI and FXIa Inhibition · Current Research in Pharmacology and Drug Discovery · 2024 · Same journal
• The simultaneous activation of μ- and δ-opioid receptors by (−)-2S-LP2 rescues allodynia with the contribution of TGF-β1 signaling in a rat chronic constriction injury model · Current Research in Pharmacology and Drug Discovery · 2025 · Same journal
• Probing into the chemopreventive properties of synthetic 1,3,6-tri-O-galloyl-α-D-glucose (α-TGG) against glioblastoma and triple-negative breast cancer-derived cell models · Current Research in Pharmacology and Drug Discovery · 2025 · Same journal
• Quercetin prevents rats from type 1 diabetic liver damage by inhibiting TGF-ꞵ/apelin gene expression · Current Research in Pharmacology and Drug Discovery · 2024 · Same journal
• Desloratadine attenuates renal ischemia-reperfusion injury through activation of the Nrf2-GCL-GSH antioxidant pathway · Current Research in Pharmacology and Drug Discovery · 2026 · Same journal
• Carnosine modulates Aβ-induced transcriptional aberrations in murine microglial cells · Current Research in Pharmacology and Drug Discovery · 2025 · Same journal
• Neuroprotective effects of naringenin on nicotine-induced anxiety and depression: Involvement of monoaminergic systems, oxidative stress, and neuroinflammation on male rats · Current Research in Pharmacology and Drug Discovery · 2025 · Same journal
• Fragment-based drug discovery: A graphical review · Current Research in Pharmacology and Drug Discovery · 2025 · Same journal
• Cyclodextrin-based therapeutics delivery systems: A review of current clinical trials · Current Research in Pharmacology and Drug Discovery · 2025 · Same journal
• Targeting c-Met in breast cancer: From mechanisms of chemoresistance to novel therapeutic strategies · Current Research in Pharmacology and Drug Discovery · 2024 · Same journal